Catalyst Pharmaceuticals initiated with an Outperform at Baird
Baird analyst Joel Beatty initiated coverage of Catalyst Pharmaceuticals (CPRX) with an Outperform rating and $28 price target Maximize Your ...
Catalyst Announces Hiring of Craig Weynand as General Counsel
Catalyst Capital Advisors LLC, a leading provider of alternative and innovative investment solutions, today announced the ...